NCT00005952View on ClinicalTrials.gov

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Brain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck CancerKidney CancerNeuroblastomaOvarian CancerSarcomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

filgrastim

DRUG

temozolomide

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER